Literature DB >> 32467245

Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.

Carlo Salvarani1,2, Gianluigi Bajocchi3, Pamela Mancuso4, Elena Galli3, Francesco Muratore3, Luigi Boiardi3, Mariagrazia Catanoso3, Nicolò Pipitone3, Giulia Cassone3, Nicolò Girolimetto3, Stefania Croci5, Luca Cimino6, Federeica Gradellini7, Marina Beltrami8, Vito Di Lernia9, Giovammi Dolci10, Marco Massari10, Anna Maria Marata11, Massimo Costantini12, Paolo Giorgi Rossi13.   

Abstract

Entities:  

Keywords:  autoimmune diseases; biological therapy; epidemiology

Mesh：

Substances：

Year:  2020        PMID： 32467245     DOI： 10.1136/annrheumdis-2020-217903

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

2.  Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.

Authors:  Paolo Corradini; Chiara Agrati; Giovanni Apolone; Alberto Mantovani; Diana Giannarelli; Vincenzo Marasco; Veronica Bordoni; Alessandra Sacchi; Giulia Matusali; Carlo Salvarani; Pier Luigi Zinzani; Renato Mantegazza; Fabrizio Tagliavini; Maria Teresa Lupo-Stanghellini; Fabio Ciceri; Silvia Damian; Antonio Uccelli; Daniela Fenoglio; Nicola Silvestris; Fausto Baldanti; Giulia Piaggio; Gennaro Ciliberto; Aldo Morrone; Franco Locatelli; Valentina Sinno; Maria Rescigno; Massimo Costantini
Journal:  Clin Infect Dis       Date:  2022-05-24       Impact factor: 20.999

3.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

Review 4.  Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.

Authors:  Lai-Shan Tam; Yoshiya Tanaka; Rohini Handa; Zhanguo Li; Jose Paulo Lorenzo; Worawit Louthrenoo; Catherine Hill; Kevin Pile; Philip C Robinson; Leonila F Dans; Li Yang Hsu; Sang-Min Lee; Jiacai Cho; A T M Tanveer Hasan; Babur Salim; Saba Samreen; Syahrul Sazliyana Shaharir; Priscilla Wong; Jeffrey Chau; Debashish Danda; Syed Atiqul Haq
Journal:  Int J Rheum Dis       Date:  2021-05-04       Impact factor: 2.454

5.  Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis.

Authors:  P Brito-Zerón; B Gracia-Tello; A Robles; A Alguacil; M Bonet; B De-Escalante; A Noblejas-Mosso; R Gómez-de-la-Torre; M Akasbi; M Pérez-de-Lis; R Pérez-Alvarez; M Ramos-Casals
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

6.  Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.

Authors:  Youn Ho Shin; Jae Il Shin; Sung Yong Moon; Hyun Young Jin; So Young Kim; Jee Myung Yang; Seong Ho Cho; Sungeun Kim; Minho Lee; Youngjoo Park; Min Seo Kim; Hong-Hee Won; Sung Hwi Hong; Andreas Kronbichler; Ai Koyanagi; Louis Jacob; Lee Smith; Keum Hwa Lee; Dong In Suh; Seung Won Lee; Dong Keon Yon
Journal:  Lancet Rheumatol       Date:  2021-06-18

7.  Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France.

Authors:  Renaud Felten; Marc Scherlinger; Jacques-Eric Gottenberg; Jean Sibilia; Thierry Martin; Laurent Arnaud; Aurélien Guffroy; Vincent Poindron; Alain Meyer; Margherita Giannini; Anne-Sophie Korganow; Christelle Sordet; Emmanuel Chatelus; Rose-Marie Javier; Aurore Meyer; Luc Pijnenburg; Jean-François Kleinmann
Journal:  Arthritis Res Ther       Date:  2021-07-13       Impact factor: 5.156

8.  Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.

Authors:  Padmanabha Shenoy; Sakir Ahmed; K C Shanoj; Veena Shenoy; Deepak Damodaran; Aparna R Menon; Bazil Alias; Divya Devakumar; A S Sageer Babu
Journal:  Clin Rheumatol       Date:  2021-06-22       Impact factor: 2.980

Review 9.  Deciphering the Role of Host Genetics in Susceptibility to Severe COVID-19.

Authors:  Madalina Elena Carter-Timofte; Sofie Eg Jørgensen; Mette Ratzer Freytag; Michelle Mølgaard Thomsen; Nanna-Sophie Brinck Andersen; Ali Al-Mousawi; Alon Schneider Hait; Trine H Mogensen
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

10.  Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.

Authors:  Rocío-V Gamboa-Cárdenas; Silvia Barzola-Cerrón; Denisse Toledo-Neira; Cristina Reátegui-Sokolova; Víctor Pimentel-Quiroz; Francisco Zevallos-Miranda; Graciela S Alarcón; Manuel Ugarte-Gil
Journal:  Clin Rheumatol       Date:  2021-06-30       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.